Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Denali Therapeutics (DNLI) Tax Rate (2019 - 2023)

Denali Therapeutics (DNLI) has disclosed Tax Rate for 5 consecutive years, with 0.02% as the latest value for Q4 2023.

  • On a quarterly basis, Tax Rate fell 3.0% to 0.02% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.02%, a 18.0% decrease, with the full-year FY2025 number at 0.02%, changed 0.0% from a year prior.
  • Tax Rate was 0.02% for Q4 2023 at Denali Therapeutics, down from 0.01% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.76% in Q4 2021 to a low of 0.14% in Q4 2019.
  • A 5-year average of 0.15% and a median of 0.01% in 2022 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: soared 46bps in 2020, then crashed -75bps in 2022.
  • Denali Therapeutics' Tax Rate stood at 0.14% in 2019, then soared by 331bps to 0.32% in 2020, then surged by 136bps to 0.76% in 2021, then plummeted by -99bps to 0.01% in 2022, then crashed by -472bps to 0.02% in 2023.
  • Per Business Quant, the three most recent readings for DNLI's Tax Rate are 0.02% (Q4 2023), 0.01% (Q4 2022), and 0.04% (Q2 2022).